Sai Life Sciences allots 2.44 lakh equity shares under employee stock option schemes
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
This tie-up will have no impact on any other brands of the company
This strategic decision will unlock significant value for our scientific and industrial products business
The team will assist the State Health Authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
This deal makes Meddo, one of the largest health-tech players in India
Subscribe To Our Newsletter & Stay Updated